IPCA Laboratories held a conference call on November 14, 2024, to discuss their Q2 FY 25 earnings, reporting an 11% growth in domestic formulations and a market share increase to 2.14%. They also noted a 15% growth in their export formulations while facing a decline in branded promotional business by 6%.